Nifty
:
24741.00
Sensex
:
80710.76
6.70 (0.03%)
-7.25 (-0.01%)
Nifty
Sensex
:
:
24741.00
80710.76
6.70 (0.03%)
-7.25 (-0.01%)

Themis Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
32/99

BSE: 530199 | NSE: THEMISMED

NSE BSE
100.30
05-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  101.79
  •  102.66
  •  99.54
  •  100.19
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  36852
  •  3719590.4
  •  317
  •  98

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 925.28
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 995.43
  • 0.50%
  • 2.39

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.15%
  • 3.23%
  • 24.15%
  • FII
  • DII
  • Others
  • 0.09%
  • 0.00%
  • 5.38%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.72
  • 11.94
  • 4.60

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.54
  • -0.18
  • -6.17

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.96
  • 2.61
  • -19.37

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.95
  • 22.31
  • 30.94

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.23
  • 3.80
  • 4.47

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.33
  • 20.21
  • 26.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
97.58
122.99
-20.66%
71.70
97.82
-26.70%
93.81
82.51
13.70%
117.01
104.78
11.67%
Expenses
107.66
93.82
14.75%
77.49
88.52
-12.46%
85.28
74.45
14.55%
99.88
92.38
8.12%
EBITDA
-10.08
29.18
-
-5.78
9.30
-
8.53
8.06
5.83%
17.13
12.40
38.15%
EBIDTM
-10.33%
23.72%
-8.07%
9.50%
9.09%
9.77%
14.64%
11.84%
Other Income
1.18
0.96
22.92%
1.55
1.10
40.91%
1.02
0.57
78.95%
1.14
2.44
-53.28%
Interest
2.47
2.36
4.66%
2.45
2.16
13.43%
2.79
2.69
3.72%
2.44
2.04
19.61%
Depreciation
2.55
2.41
5.81%
2.53
3.06
-17.32%
2.54
3.10
-18.06%
2.45
3.07
-20.20%
PBT
-13.93
25.37
-
-9.21
5.18
-
4.22
2.85
48.07%
13.37
9.74
37.27%
Tax
0.16
6.66
-97.60%
-1.46
2.11
-
1.14
0.85
34.12%
3.50
2.64
32.58%
PAT
-14.08
18.71
-
-7.75
3.07
-
3.08
2.00
54.00%
9.87
7.10
39.01%
PATM
-14.43%
15.21%
-10.81%
3.14%
3.28%
2.42%
8.44%
6.77%
EPS
-1.54
2.68
-
-1.05
0.72
-
0.06
0.80
-92.50%
1.55
1.23
26.02%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
380.10
405.51
381.76
354.32
394.61
230.67
201.59
183.75
209.50
216.66
232.43
Net Sales Growth
-6.86%
6.22%
7.74%
-10.21%
71.07%
14.43%
9.71%
-12.29%
-3.30%
-6.78%
 
Cost Of Goods Sold
143.12
108.22
115.43
100.52
131.00
67.35
51.97
58.82
57.75
55.66
71.38
Gross Profit
236.98
297.30
266.33
253.81
263.62
163.33
149.62
124.94
151.75
160.99
161.06
GP Margin
62.35%
73.32%
69.76%
71.63%
66.81%
70.81%
74.22%
67.99%
72.43%
74.31%
69.29%
Total Expenditure
370.31
356.46
330.26
286.87
298.98
181.18
165.93
181.48
184.98
184.29
194.28
Power & Fuel Cost
-
11.81
13.46
11.83
12.18
11.32
11.49
9.70
8.41
9.77
10.83
% Of Sales
-
2.91%
3.53%
3.34%
3.09%
4.91%
5.70%
5.28%
4.01%
4.51%
4.66%
Employee Cost
-
96.38
82.41
66.15
51.97
39.99
44.28
45.69
44.65
40.00
36.30
% Of Sales
-
23.77%
21.59%
18.67%
13.17%
17.34%
21.97%
24.87%
21.31%
18.46%
15.62%
Manufacturing Exp.
-
44.53
41.64
36.95
40.23
21.41
24.01
22.45
27.46
31.30
31.28
% Of Sales
-
10.98%
10.91%
10.43%
10.19%
9.28%
11.91%
12.22%
13.11%
14.45%
13.46%
General & Admin Exp.
-
37.72
29.71
24.29
18.66
12.03
14.05
17.57
18.93
18.86
14.75
% Of Sales
-
9.30%
7.78%
6.86%
4.73%
5.22%
6.97%
9.56%
9.04%
8.70%
6.35%
Selling & Distn. Exp.
-
31.33
29.30
26.74
26.08
14.92
12.28
17.71
18.27
16.70
12.05
% Of Sales
-
7.73%
7.67%
7.55%
6.61%
6.47%
6.09%
9.64%
8.72%
7.71%
5.18%
Miscellaneous Exp.
-
26.48
18.30
20.40
18.86
14.16
7.86
9.54
9.51
11.99
12.05
% Of Sales
-
6.53%
4.79%
5.76%
4.78%
6.14%
3.90%
5.19%
4.54%
5.53%
7.61%
EBITDA
9.80
49.05
51.50
67.45
95.63
49.49
35.66
2.27
24.52
32.37
38.15
EBITDA Margin
2.58%
12.10%
13.49%
19.04%
24.23%
21.45%
17.69%
1.24%
11.70%
14.94%
16.41%
Other Income
4.89
4.67
4.76
11.50
6.54
3.62
3.46
2.67
3.49
3.32
3.19
Interest
10.15
10.04
9.38
9.56
8.77
12.71
12.88
11.82
11.87
11.84
12.33
Depreciation
10.07
9.93
12.25
10.49
9.48
8.55
8.27
7.99
7.42
7.47
11.89
PBT
-5.55
33.75
34.64
58.90
83.92
31.86
17.97
-14.87
8.74
16.37
17.13
Tax
3.34
9.84
9.92
15.61
22.38
5.63
2.09
-1.84
0.10
1.60
1.91
Tax Rate
-60.18%
29.16%
28.64%
26.50%
26.67%
17.67%
11.63%
12.37%
1.14%
9.77%
11.15%
PAT
-8.88
29.83
43.52
56.90
72.88
26.23
15.88
-13.01
8.70
14.77
15.22
PAT before Minority Interest
-8.88
29.83
43.52
56.90
72.88
26.23
15.88
-13.03
8.64
14.77
15.22
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.06
0.00
0.00
PAT Margin
-2.34%
7.36%
11.40%
16.06%
18.47%
11.37%
7.88%
-7.08%
4.15%
6.82%
6.55%
PAT Growth
-128.76%
-31.46%
-23.51%
-21.93%
177.85%
65.18%
-
-
-41.10%
-2.96%
 
EPS
-0.97
3.24
4.73
6.18
7.92
2.85
1.73
-1.41
0.95
1.61
1.65

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
402.60
377.67
339.44
287.49
218.51
183.02
158.09
168.91
152.44
74.03
Share Capital
9.20
9.20
9.20
9.20
9.19
9.19
9.18
9.18
9.04
8.52
Total Reserves
393.40
368.46
330.17
278.05
208.95
173.35
148.31
159.18
141.36
65.51
Non-Current Liabilities
29.31
35.77
35.39
30.77
24.33
7.51
2.71
6.72
7.60
70.83
Secured Loans
16.39
21.19
18.62
10.91
5.73
0.09
0.14
0.01
0.47
15.89
Unsecured Loans
2.22
5.59
9.83
12.97
16.47
11.76
9.21
11.48
11.93
47.52
Long Term Provisions
1.87
1.60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.54
Current Liabilities
165.99
162.28
149.38
123.52
128.31
154.81
146.69
124.94
124.17
129.66
Trade Payables
51.44
47.29
40.04
31.87
30.79
29.68
35.04
30.55
31.63
34.90
Other Current Liabilities
53.68
49.95
40.28
29.93
39.09
46.86
43.72
29.76
38.13
37.04
Short Term Borrowings
43.35
47.36
48.91
43.10
56.93
76.61
66.86
63.73
53.45
51.88
Short Term Provisions
17.52
17.68
20.14
18.61
1.49
1.66
1.07
0.90
0.95
5.83
Total Liabilities
597.90
575.72
524.21
441.78
371.15
345.34
307.47
300.51
284.21
274.52
Net Block
172.36
168.37
162.20
144.00
133.10
116.31
123.41
125.90
123.71
117.35
Gross Block
252.56
239.28
221.02
192.36
172.24
147.14
146.06
140.78
131.17
212.16
Accumulated Depreciation
80.19
70.92
58.82
48.36
39.14
30.83
22.66
14.87
7.46
94.80
Non Current Assets
284.17
273.25
249.43
213.62
185.67
164.85
157.61
157.47
159.81
141.68
Capital Work in Progress
2.51
2.60
2.60
2.56
2.47
7.54
2.45
2.47
8.95
5.79
Non Current Investment
94.77
88.89
70.00
56.31
44.96
35.47
26.64
24.38
21.83
5.64
Long Term Loans & Adv.
13.34
12.46
12.81
6.90
2.83
2.91
2.67
2.39
3.01
12.19
Other Non Current Assets
1.18
0.93
1.82
3.84
2.31
2.62
2.45
2.33
2.30
0.70
Current Assets
313.74
302.47
274.78
228.16
185.47
180.49
149.86
143.04
124.40
132.83
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.05
0.00
Inventories
84.31
70.57
68.95
60.81
58.49
54.61
53.63
49.58
48.44
58.26
Sundry Debtors
177.10
177.95
145.02
100.56
77.61
102.48
72.91
68.63
48.25
47.57
Cash & Bank
12.84
19.30
18.89
26.50
24.63
5.29
3.45
6.91
8.62
14.30
Other Current Assets
39.48
7.44
6.67
5.94
24.73
18.11
19.87
17.91
18.04
12.70
Short Term Loans & Adv.
32.67
27.21
35.24
34.34
18.84
12.28
14.45
12.57
12.72
11.34
Net Current Assets
147.74
140.19
125.40
104.64
57.16
25.68
3.18
18.09
0.23
3.18
Total Assets
597.91
575.72
524.21
441.78
371.14
345.34
307.47
300.51
284.21
274.51

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
34.71
22.09
16.09
34.39
56.98
0.33
10.92
7.86
-1.51
25.76
PBT
39.67
53.44
72.51
95.26
41.33
26.87
-12.60
11.33
17.56
30.52
Adjustment
10.89
-1.48
0.03
-0.24
7.66
9.33
16.74
14.93
15.92
10.05
Changes in Working Capital
-5.11
-20.92
-40.30
-42.55
7.90
-35.63
7.08
-19.05
-35.16
-0.57
Cash after chg. in Working capital
45.46
31.05
32.25
52.47
56.90
0.57
11.22
7.21
-1.67
40.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-12.33
Tax Paid
-10.75
-8.96
-16.15
-18.07
0.08
-0.24
-0.30
0.65
0.16
-1.91
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-12.17
-15.95
-23.96
-15.59
-15.65
-5.47
-3.72
-0.04
-4.14
-7.17
Net Fixed Assets
-13.19
-18.26
-28.70
-20.21
-20.03
-6.16
-5.34
-3.11
20.82
-6.64
Net Investments
0.06
-0.11
-0.05
-0.03
-0.02
0.06
-0.01
1.01
-1.33
0.01
Others
0.96
2.42
4.79
4.65
4.40
0.63
1.63
2.06
-23.63
-0.54
Cash from Financing Activity
-25.90
-8.77
0.14
-17.55
-25.65
6.72
-9.94
-9.11
5.27
-13.29
Net Cash Inflow / Outflow
-3.36
-2.62
-7.73
1.26
15.68
1.59
-2.74
-1.29
-0.38
5.31
Opening Cash & Equivalents
9.92
12.55
20.28
19.02
3.34
1.75
4.49
5.78
6.16
-39.67
Closing Cash & Equivalent
6.56
9.92
12.55
20.28
19.02
3.34
1.75
4.49
5.78
-34.36

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
43.74
41.03
36.88
31.22
237.41
198.67
171.54
183.39
166.38
86.94
ROA
5.08%
7.91%
11.78%
17.93%
7.32%
4.86%
-4.29%
2.95%
5.29%
5.52%
ROE
7.65%
12.14%
18.16%
28.84%
13.09%
9.34%
-8.00%
5.42%
13.16%
22.85%
ROCE
10.37%
13.88%
20.59%
31.07%
15.21%
11.81%
-1.25%
8.52%
12.92%
14.69%
Fixed Asset Turnover
1.65
1.66
1.71
2.16
1.44
1.38
1.28
1.56
1.32
1.13
Receivable days
159.79
154.39
126.49
82.40
142.49
158.78
140.57
100.75
77.33
72.04
Inventory Days
69.71
66.70
66.84
55.18
89.48
97.99
102.51
84.49
86.11
93.26
Payable days
166.51
138.08
130.58
87.30
163.89
75.58
71.78
69.42
73.88
99.57
Cash Conversion Cycle
62.99
83.02
62.75
50.27
68.08
181.20
171.29
115.83
89.56
65.73
Total Debt/Equity
0.21
0.25
0.27
0.27
0.39
0.54
0.52
0.48
0.55
1.73
Interest Cover
4.95
6.70
8.58
11.86
3.51
2.40
-0.26
1.74
2.38
2.39

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Themis Medicare - Quarterly Results
    1st Aug 2025, 18:51 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.